Dr David A Sterling, MD | |
4100 Outpatient Circle #616, Little Rock, AR 72205 | |
(501) 686-6324 | |
(501) 686-5855 |
Full Name | Dr David A Sterling |
---|---|
Gender | Male |
Speciality | Plastic Surgery |
Location | 4100 Outpatient Circle #616, Little Rock, Arkansas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1801327051 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | E-16628 (Arkansas) | Primary |
Entity Name | University Of Arkansas For Medical Sciences |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588654016 PECOS PAC ID: 4082528955 Enrollment ID: O20031219000706 |
News Archive
A new framework to eliminate human rabies and save tens of thousands of lives each year has been launched today by the World Health Organization, the World Organization for Animal Health, the Food and Agriculture Organization of the United Nations and the Global Alliance for the Control of Rabies.
Building on their 2005 discovery of an enzyme that is a natural tumor suppressor, researchers at the University of California, San Diego (UCSD) School of Medicine have now identified two variants of that enzyme which could provide new targets for therapies to treat diabetes, heart and neurological disease.
A study from investigators at Massachusetts General Hospital finds that a blood transfusion practice previously studied only in patients with severe traumatic injuries has been widely adopted within the hospital for surgical patients without traumatic injuries.
Cell Therapeutics, Inc.today announced that the Gynecologic Oncology Group informed CTI that it has completed patient enrollment in the GOG-0212 Phase 3 clinical trial of investigational agent paclitaxel poliglumex as maintenance therapy in ovarian cancer.
Under a unique collaboration, the National Council on Aging with support from the Bristol-Myers Squibb Foundation and WellPoint are—for the first time—bringing a proven and affordable face-to-face and online support program to help people manage their Type 2 diabetes.
› Verified 7 days ago
Entity Name | University Of Arkansas For Medical Sciences |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346230968 PECOS PAC ID: 4082528955 Enrollment ID: O20040115000431 |
News Archive
A new framework to eliminate human rabies and save tens of thousands of lives each year has been launched today by the World Health Organization, the World Organization for Animal Health, the Food and Agriculture Organization of the United Nations and the Global Alliance for the Control of Rabies.
Building on their 2005 discovery of an enzyme that is a natural tumor suppressor, researchers at the University of California, San Diego (UCSD) School of Medicine have now identified two variants of that enzyme which could provide new targets for therapies to treat diabetes, heart and neurological disease.
A study from investigators at Massachusetts General Hospital finds that a blood transfusion practice previously studied only in patients with severe traumatic injuries has been widely adopted within the hospital for surgical patients without traumatic injuries.
Cell Therapeutics, Inc.today announced that the Gynecologic Oncology Group informed CTI that it has completed patient enrollment in the GOG-0212 Phase 3 clinical trial of investigational agent paclitaxel poliglumex as maintenance therapy in ovarian cancer.
Under a unique collaboration, the National Council on Aging with support from the Bristol-Myers Squibb Foundation and WellPoint are—for the first time—bringing a proven and affordable face-to-face and online support program to help people manage their Type 2 diabetes.
› Verified 7 days ago
Entity Name | Arkansas Childrens Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598773079 PECOS PAC ID: 2769477744 Enrollment ID: O20040419000796 |
News Archive
A new framework to eliminate human rabies and save tens of thousands of lives each year has been launched today by the World Health Organization, the World Organization for Animal Health, the Food and Agriculture Organization of the United Nations and the Global Alliance for the Control of Rabies.
Building on their 2005 discovery of an enzyme that is a natural tumor suppressor, researchers at the University of California, San Diego (UCSD) School of Medicine have now identified two variants of that enzyme which could provide new targets for therapies to treat diabetes, heart and neurological disease.
A study from investigators at Massachusetts General Hospital finds that a blood transfusion practice previously studied only in patients with severe traumatic injuries has been widely adopted within the hospital for surgical patients without traumatic injuries.
Cell Therapeutics, Inc.today announced that the Gynecologic Oncology Group informed CTI that it has completed patient enrollment in the GOG-0212 Phase 3 clinical trial of investigational agent paclitaxel poliglumex as maintenance therapy in ovarian cancer.
Under a unique collaboration, the National Council on Aging with support from the Bristol-Myers Squibb Foundation and WellPoint are—for the first time—bringing a proven and affordable face-to-face and online support program to help people manage their Type 2 diabetes.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr David A Sterling, MD 4301 W Markham St # 783, Little Rock, AR 72205-7101 Ph: (501) 686-8000 | Dr David A Sterling, MD 4100 Outpatient Circle #616, Little Rock, AR 72205 Ph: (501) 686-6324 |
News Archive
A new framework to eliminate human rabies and save tens of thousands of lives each year has been launched today by the World Health Organization, the World Organization for Animal Health, the Food and Agriculture Organization of the United Nations and the Global Alliance for the Control of Rabies.
Building on their 2005 discovery of an enzyme that is a natural tumor suppressor, researchers at the University of California, San Diego (UCSD) School of Medicine have now identified two variants of that enzyme which could provide new targets for therapies to treat diabetes, heart and neurological disease.
A study from investigators at Massachusetts General Hospital finds that a blood transfusion practice previously studied only in patients with severe traumatic injuries has been widely adopted within the hospital for surgical patients without traumatic injuries.
Cell Therapeutics, Inc.today announced that the Gynecologic Oncology Group informed CTI that it has completed patient enrollment in the GOG-0212 Phase 3 clinical trial of investigational agent paclitaxel poliglumex as maintenance therapy in ovarian cancer.
Under a unique collaboration, the National Council on Aging with support from the Bristol-Myers Squibb Foundation and WellPoint are—for the first time—bringing a proven and affordable face-to-face and online support program to help people manage their Type 2 diabetes.
› Verified 7 days ago
Gary E Talbert, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 9500 Kanis Road, Ste 501, Little Rock, AR 72205 Phone: 501-219-8388 Fax: 501-217-2520 | |
Melanie Denise Prince, MD Plastic Surgery Medicare: May Accept Medicare Assignments Practice Location: 8201 Cantrell Rd, Ste 265, Little Rock, AR 72227 Phone: 501-225-3333 Fax: 501-225-3338 | |
Kristopher B Shewmake, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 9500 Kanis Road, Ste 501, Little Rock, AR 72205 Phone: 501-219-8388 Fax: 501-217-2520 | |
David H Bauer, MD Plastic Surgery Medicare: May Accept Medicare Assignments Practice Location: 9500 Kanis Road, Suite 501, Little Rock, AR 72205 Phone: 501-219-8388 Fax: 501-217-2520 | |
Roger Wilbert Anderson, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2200 N Rodney Parham Rd, Suite 200, Little Rock, AR 72212 Phone: 501-219-8000 | |
Zachary Tuck Young, Plastic Surgery Medicare: May Accept Medicare Assignments Practice Location: 9500 Kanis Rd Ste 502, Little Rock, AR 72205 Phone: 501-219-8388 | |
Dr. Ramona L Bates, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 500 S University Ave, Suite 701, Little Rock, AR 72205 Phone: 501-663-3385 |